Listed by the USPTO as BURKE, MATTHEW RYAN
Tech Center 1700 • Art Units: 1619 1763
This examiner grants 0% of resolved cases
BURKE, MATTHEW RYAN is assigned to technology center 1700 and art unit 1619. The profile contains 1 resolved case, an allowance rate of 0.0%, an interview lift of 0.0%, and a median of 917 days to allowance. Because the resolved-case record is limited, these figures should not be treated as a broad measure of prosecution behavior. The reported timing can nevertheless inform preliminary docket planning.
The listed companies are Henkel AG & Co. KGaA, The Procter & Gamble Company, and Syngenta AG. The listed firms are BakerHostetler, BLANK ROME LLP, and CANTOR COLBURN LLP. Applicants should rely heavily on application-specific claim analysis and maintain flexible prosecution options until a larger record becomes available.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18805889 | HAIR CARE COMPOSITION | Final Rejection | The Procter & Gamble Company |
| 18839330 | HERBICIDAL QUINOLONE DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18840308 | AMPHOTERIC ALKYLAMIDO BETAINES PRODUCED FROM MACAÚBA PALM OIL | Final Rejection | BASF SE |
| 18840401 | Functionalized Nanoclusters and Their Use in Treating Bacterial Infections | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18797678 | OXIDATIVE HAIR TREATMENT AGENT WITH A CONTROLLED HEAT DEVELOPMENT BASED ON ENVIRONMENTALLY FRIENDLY CONTENTS | Non-Final OA | Henkel AG & Co. KGaA |
| 18741918 | COLOR RETENTION SYSTEMS USING DENDRIMER AND CHITOSAN COMPLEX FOR LONG-LASTING EFFECT | Final Rejection | Henkel AG & Co. KGaA |
| 18544223 | OIL-IN-WATER DISPERSION COMPRISING HYDROPHOBIC POLYMER AND BIOSURFACTANT | Final Rejection | L'OREAL |
| 18833758 | COSMETIC PRODUCT COMPRISING A FLEXIBLE CONTAINER AND AN AQUEOUS OXIDATIVE COMPOSITION CONTAINED THEREIN | Non-Final OA | KAO CORPORATION |
| 18621369 | PERSONAL CARE COMPOSITIONS | Final Rejection | COLGATE-PALMOLIVE COMPANY |
| 18849428 | BIODEGRADABLE CONTROLLED RELEASE ANTIVIRAL AGENT IMPLANTS | Non-Final OA | Yale University |
| 18770080 | DEODORANT FRAGRANCE COMPOSITION | Final Rejection | TAKASAGO INTERNATIONAL CORPORATION |
| 18833618 | SOLVENT MIXTURES COMPRISING 1,3-BUTYLENE GLYCOL AND TRIETHYL-CITRATE | Non-Final OA | Givaudan SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy0.0% of resolved applications examined by Matthew Ryan Burke were allowed (1 resolved cases), compared with 22.7% across Art Unit 1619 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Matthew Ryan Burke took 917 days on average from filing to allowance.
Matthew Ryan Burke examines applications in Art Unit 1619 in Tech Center 1700 (Chemistry & Materials).
